DE69738641D1 - Lebend-impfstoff gegen heliobacter pylori - Google Patents

Lebend-impfstoff gegen heliobacter pylori

Info

Publication number
DE69738641D1
DE69738641D1 DE69738641T DE69738641T DE69738641D1 DE 69738641 D1 DE69738641 D1 DE 69738641D1 DE 69738641 T DE69738641 T DE 69738641T DE 69738641 T DE69738641 T DE 69738641T DE 69738641 D1 DE69738641 D1 DE 69738641D1
Authority
DE
Germany
Prior art keywords
vaccine against
heliobacter pylori
living vaccine
pylori
against heliobacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738641T
Other languages
English (en)
Inventor
Thomas F Meyer
Rainer Haas
Zhengxin Yan
Oscar Gomez-Duarte
Bernadette Lucas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Application granted granted Critical
Publication of DE69738641D1 publication Critical patent/DE69738641D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69738641T 1996-10-11 1997-09-01 Lebend-impfstoff gegen heliobacter pylori Expired - Lifetime DE69738641D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96116337A EP0835928A1 (de) 1996-10-11 1996-10-11 Helicobacter Pylori Lebendimpfstoff
PCT/EP1997/004744 WO1998016552A1 (en) 1996-10-11 1997-09-01 Helicobacter pylori live vaccine

Publications (1)

Publication Number Publication Date
DE69738641D1 true DE69738641D1 (de) 2008-05-29

Family

ID=8223286

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738641T Expired - Lifetime DE69738641D1 (de) 1996-10-11 1997-09-01 Lebend-impfstoff gegen heliobacter pylori

Country Status (15)

Country Link
EP (2) EP0835928A1 (de)
JP (1) JP2001510986A (de)
KR (1) KR100510928B1 (de)
CN (1) CN1215167C (de)
AT (1) ATE392429T1 (de)
AU (1) AU734635B2 (de)
BR (1) BR9713254A (de)
CA (1) CA2268033A1 (de)
DE (1) DE69738641D1 (de)
IL (1) IL129366A0 (de)
NO (1) NO991692L (de)
NZ (1) NZ335050A (de)
PL (1) PL332575A1 (de)
TR (1) TR199901450T2 (de)
WO (1) WO1998016552A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248551B1 (en) * 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
JP2002518343A (ja) * 1998-06-19 2002-06-25 メリウクス オラバクス ヘリコバクター感染に対する非経口的免疫処置法におけるltおよびct
AU8464398A (en) * 1998-07-16 2000-02-07 Cheil Jedang Corporation Urease based vaccine against (helicobacter) infection
WO2001083531A1 (en) * 2000-04-27 2001-11-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens
CA3219727A1 (en) * 2010-12-22 2012-06-28 Intervet International B.V. Vaccines comprising live aro mutant bordetella bronchiseptica
AU2012239880B2 (en) 2011-04-08 2017-06-15 Tufts Medical Center, Inc. Pepducin design and use
AU2016354478B2 (en) 2015-11-13 2021-07-22 Oasis Pharmaceuticals, LLC Protease-activated receptor-2 modulators
CN112048008B (zh) * 2020-08-12 2021-06-15 河北医科大学第四医院(河北省肿瘤医院) 一种幽门螺杆菌b细胞耐受表位及其制备的抗体
CN112143741B (zh) * 2020-09-07 2022-09-20 中国科学院南海海洋研究所 一种生物膜基因岛GIVal43097及其切除方法
CN112143750B (zh) * 2020-10-13 2022-12-27 宁夏医科大学 靶向m细胞的重组乳酸菌表面展示系统、重组乳酸菌疫苗及制备方法与应用
CN112190704B (zh) * 2020-10-13 2022-11-15 宁夏医科大学 M细胞靶向性重组乳酸菌疫苗及制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695983A (en) * 1990-12-18 1997-12-09 The General Hospital Corporation Salmonella vaccines
DE4041045A1 (de) * 1990-12-20 1992-07-02 Max Planck Gesellschaft Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
JPH08509873A (ja) * 1993-05-19 1996-10-22 アンスティテュ・パストゥール ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
EP0654273A1 (de) * 1993-11-18 1995-05-24 Harry H. Leveen Pharmazeutisches Produkt und Behandlungsverfahren
WO1996026740A1 (en) * 1995-02-27 1996-09-06 Enteron Limited Partnership Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms
ATE433325T1 (de) * 1995-04-28 2009-06-15 Merieux Oravax Snc Multimerer, rekombinanter urease impfstoff

Also Published As

Publication number Publication date
AU4208497A (en) 1998-05-11
ATE392429T1 (de) 2008-05-15
CN1215167C (zh) 2005-08-17
EP0931093B1 (de) 2008-04-16
NZ335050A (en) 2000-08-25
PL332575A1 (en) 1999-09-27
TR199901450T2 (xx) 1999-10-21
NO991692D0 (no) 1999-04-09
EP0931093A1 (de) 1999-07-28
EP0835928A1 (de) 1998-04-15
WO1998016552A1 (en) 1998-04-23
AU734635B2 (en) 2001-06-21
CA2268033A1 (en) 1998-04-23
KR20000049090A (ko) 2000-07-25
IL129366A0 (en) 2000-02-17
CN1246867A (zh) 2000-03-08
JP2001510986A (ja) 2001-08-07
KR100510928B1 (ko) 2005-08-31
BR9713254A (pt) 1999-11-03
NO991692L (no) 1999-06-04

Similar Documents

Publication Publication Date Title
GB2303854B (en) Helicobacter proteins and vaccines
DE69331901D1 (de) Impfstoff auf urease-basis gegen helicobacter infektionen
BR9710012B1 (pt) vacina veterinária viva recombinante e fórmula de vacina multivalente.
DE69738641D1 (de) Lebend-impfstoff gegen heliobacter pylori
BR9605153B1 (pt) vacina de combinação, e, kit de vacinação.
DE69426051D1 (de) Infektiösen Bronchitis Virus 4/91 enthaltender Geflügel-Impfstoff
DK0745387T3 (da) Adjuvanser til virale vacciner
DK0939648T3 (da) Rotavirusvaccineformuleringer
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
HU9701586D0 (en) Improved inactivated vaccines
ATE334697T1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
GB9818133D0 (en) Vaccine
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
DE69331459T2 (de) Parenterale immunisierung gegen rotavirus
DE69130953D1 (de) Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie
SE9702240D0 (sv) Vaccine compositions III

Legal Events

Date Code Title Description
8332 No legal effect for de